Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at pembrolizumab for men with prostate cancer (KEYNOTE-199)

Overview

Cancer types:

Prostate cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for men with prostate cancer that has continued to grow or spread (metastatic cancer) despite hormone treatment.

It is for men who either:

  • have had chemotherapy with a drug called docetaxel

  • have had hormone treatment with a drug called enzalutamide. And haven't had chemotherapy with docetaxel

Recruitment start: 15 August 2016

Recruitment end: 6 December 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Johann de Bono

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 19 Dec 2018

CRUK internal database number: 14231

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.